Clinical Trials Sponsored by Chinese Society of Lung Cancer

Total 2282 results

Cancer Institute and Hospital, Chinese Academy...

Recruiting

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

Recurrent Nasopharyngeal Carcinoma | Metastatic Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Active, not recruiting

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

Cervical Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Esophageal Cancer | Unresectable Malignant Neoplasm | Chemoradiotherapy | Nimotuzumab

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer Surgery

Esophageal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma

Gastric Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer

Neutropenia

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection

Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Enrolling by invitation

Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Rectal Cancer

Gastrointestinal Neoplasms | Intestinal Neoplasms | Rectal Diseases | Rectal Neoplasms | Lymph Node Metastasis | Oxaliplatin | Cancer of Rectum and Anus

China
Cancer Institute and Hospital, Chinese Academy...

Active, not recruiting

Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC

Chemotherapy | Gastric Cancer Stage IV | Tislelizumab | First-line

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Multivisceral Radical Resection for Surgical T4b Colorectal Cancer: Propensity Score-matched Study Comparing the the Laparoscopic and Open Approaches (C-PelvEx-01)

Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

The Clinical Effect of Adaptive Posture-balance Cardiac Rehabilitation Exercise on Cardiovascular Diseases

Cardiovascular Diseases | Cardiac Rehabilitation | Exercise Therapy | Balance Exercises

China
Cancer Institute and Hospital, Chinese Academy...

Active, not recruiting

Purified Inactivated Japanese Encephalitis Vaccine

Japanese Encephalitis Virus Disease

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China

Esophageal Neoplasms

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

Rectal Neoplasms Malignant

China
Cancer Institute and Hospital, Chinese Academy...

Enrolling by invitation

The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

COVID-19

Brazil, Malaysia
Cancer Institute and Hospital, Chinese Academy...

Completed

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

Esophageal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer

Esophageal Cancer | Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Comparison of Two Bending Angles for Nasotracheal Intubation With a Malleable Vedio Stylet

Intubation;Difficult

China
Cancer Institute and Hospital, Chinese Academy...

Completed

A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer

Breast Neoplasms | Hypothyroidism | Radiation Toxicity

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma

Lymphoid Neoplasm

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

Vomiting | Head Neck Cancer | Nausea Post Chemotherapy

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

Sarcoma
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer

Hormone Receptor Positive Advanced Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma.

Diffuse Large B-Cell Lymphoma | Sintilimab | TP53 Mutation
Cancer Institute and Hospital, Chinese Academy...

Unknown

Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

Breast Cancer
Cancer Institute and Hospital, Chinese Academy...

Completed

Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases

Brain Metastases

China
Cancer Institute and Hospital, Chinese Academy...

Completed

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

Stomach Neoplasms | Chemotherapy | Neoadjuvant Therapy | Chemoradiotherapy

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer (PICARES)

Extensive-stage Small Cell Lung Cancer | Radiotherapy | Immunotherapy

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer (Pyrotinib)

Breast Cancer | Brain Metastases

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain

Pain | Physicians | Oxycodone

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy

Esophagus Cancer | Esophagogastric Junction Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer

Triple-negative Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

Adenocarcinoma | NSCLC | Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy...

Unknown

Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer

Anal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Factors Influencing Cancer Patients Participation in Clinical Trials in China.

Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

FSRT Combined With TMZ for Large BMs: a PSM Study

Chemotherapy | Brain Metastases | Radiotherapy
Cancer Institute and Hospital, Chinese Academy...

Completed

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

Esophageal Neoplasms

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer

Cervical Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer

Refractory Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

Pancreatic Neuroendocrine Tumor

China

Clinical Trials Sponsored by Chinese Society of Lung Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations